Westchester Capital Management (New York)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Westchester Capital Management (New York)’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-839,800	Closed	-$44.1M	–	307
2020 Q3	$44.1M	Buy	+839,800	New	+$34.8M	1.86%	15

Westchester Capital Management (New York)'s MNTA Position: Q4 2020 in Review

Westchester Capital Management (New York) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 839,800 shares — an estimated $44.1M sold.

Westchester Capital Management (New York) first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $44.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Westchester Capital Management (New York) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Westchester Capital Management (New York) sold 839,800 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $44.1M.
Westchester Capital Management (New York) first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Westchester Capital Management (New York)'s Momenta Pharmaceuticals, Inc. position peaked at $44.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2020, filed 12 Feb 2021.